Harvard Bioscience
HBIO
HBIO
60 hedge funds and large institutions have $7.29M invested in Harvard Bioscience in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
69% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 29
Holders
60
Holding in Top 10
–
Calls
$32K
Puts
–
Top Buyers
| 1 | +$256K | |
| 2 | +$131K | |
| 3 | +$93.1K | |
| 4 |
WN
Williams & Novak
Westlake Village,
California
|
+$80.1K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$48.6K |
Top Sellers
| 1 | -$426K | |
| 2 | -$369K | |
| 3 | -$299K | |
| 4 |
BlackRock
New York
|
-$234K |
| 5 |
Goldman Sachs
New York
|
-$92.5K |
